Christopher Posner
Vorstandsvorsitzender bei CARA THERAPEUTICS, INC.
Vermögen: 123 609 $ am 30.04.2024
Profil
Christopher A.
Posner is currently the President, Chief Executive Officer & Director at CARA Therapeutics, Inc. Prior to his current position, he served as the President & Chief Executive Officer at Leo Pharma, Inc. from 2017 to 2021.
He also held the position of Head-Worldwide Commercial Operations at R-Pharm US LLC from 2014 to 2017.
Mr. Posner has an undergraduate degree from Villanova University and an MBA from The Fuqua School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
CARA THERAPEUTICS INC
0,32% | 02.05.2024 | 176 585 ( 0,32% ) | 123 610 $ | 30.04.2024 |
Aktive Positionen von Christopher Posner
Unternehmen | Position | Beginn |
---|---|---|
CARA THERAPEUTICS, INC. | Vorstandsvorsitzender | 09.11.2021 |
Ehemalige bekannte Positionen von Christopher Posner
Unternehmen | Position | Ende |
---|---|---|
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Vorstandsvorsitzender | 01.10.2021 |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01.01.2017 |
ZEVRA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Christopher Posner
The Fuqua School of Business | Masters Business Admin |
Villanova University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CARA THERAPEUTICS, INC. | Health Technology |
ZEVRA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Retail Trade |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | Health Technology |